Jupiter Topco LLC Takes $70.98 Million Position in Heartflow, Inc. $HTFL

Jupiter Topco LLC purchased a new stake in shares of Heartflow, Inc. (NASDAQ:HTFL) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 2,419,336 shares of the company’s stock, valued at approximately $70,983,000.

Other large investors have also recently added to or reduced their stakes in the company. XXEC Inc. purchased a new position in Heartflow in the second quarter worth approximately $2,524,764,000. BlackRock Inc. purchased a new stake in Heartflow in the second quarter valued at $152,502,000. Wellington Management Group LLP acquired a new position in shares of Heartflow in the 3rd quarter valued at $164,263,000. Schusterman Interests LLC purchased a new position in shares of Heartflow during the 3rd quarter worth $65,274,000. Finally, Capricorn Investment Group LLC acquired a new stake in shares of Heartflow during the 4th quarter worth about $48,178,000.

Insider Activity

In other Heartflow news, CEO John C.M. Farquhar sold 27,230 shares of the company’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $50.00, for a total value of $1,361,500.00. Following the completion of the transaction, the chief executive officer owned 360,814 shares in the company, valued at $18,040,700. This represents a 7.02% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the company’s stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $41.23, for a total transaction of $380,099.37. Following the completion of the transaction, the insider directly owned 86,459 shares of the company’s stock, valued at approximately $3,564,704.57. The trade was a 9.64% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 191,271 shares of company stock valued at $7,089,136 in the last ninety days. Company insiders own 7.70% of the company’s stock.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Stifel Nicolaus boosted their target price on Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, August 14th. Wells Fargo & Company boosted their price target on shares of Heartflow from $37.00 to $39.00 and gave the stock an “overweight” rating in a report on Friday, August 14th. William Blair started coverage on Heartflow in a report on Monday, May 4th. They issued an “outperform” rating on the stock. Weiss Ratings raised shares of Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Finally, Canaccord Genuity Group lifted their price target on Heartflow from $37.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $43.43.

Heartflow Stock Down 1.7%

NASDAQ HTFL opened at $48.10 on Friday. The stock has a market cap of $4.18 billion and a price-to-earnings ratio of -26.28. The business has a fifty day moving average of $31.97 and a 200-day moving average of $28.93. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $51.19.

Heartflow (NASDAQ:HTFL) last issued its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.22) by $0.15. The firm had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.Heartflow’s revenue for the quarter was up 47.7% on a year-over-year basis. As a group, analysts anticipate that Heartflow, Inc. will post -0.75 EPS for the current year.

About Heartflow

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.